Prestige Consumer Healthcare Inc. PBH
Prestige Consumer Healthcare Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($58.38); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Prestige Consumer Healthcare Inc. trades at about 13.4× earnings — below its 10-year norm (10-year range 4.6×–44.2×, median 17.2×).
Shaded band = 10-year range (4.6×–44.2×); dot = today's 13.4×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 54.7% | 55.8% | 55.5% | 55.4% | 57.1% | 58.0% | 57.3% | 56.9% | 55.4% | 56.7% |
| Operating margin | 28.4% | 29.6% | 30.4% | -2.0% | 30.4% | 31.5% | 30.2% | 6.9% | 20.7% | 23.3% |
| Net margin | 17.5% | 18.9% | 18.6% | -7.3% | 18.9% | 17.5% | 14.8% | -3.7% | 32.6% | 7.9% |
| FCF margin | 22.6% | 21.4% | 21.3% | 19.7% | 23.0% | 22.6% | 21.0% | 18.3% | 19.0% | 16.5% |
| Return on assets | 5.4% | 6.3% | 6.3% | -2.5% | 5.6% | 4.8% | 4.0% | -1.0% | 9.0% | 1.8% |
| Return on equity | 10.1% | 11.7% | 12.6% | -5.7% | 13.0% | 12.1% | 12.2% | -3.3% | 28.8% | 8.4% |
| Debt / equity | 0.53× | 0.54× | 0.69× | 0.93× | 0.94× | 1.09× | 1.48× | 1.64× | 1.69× | 2.67× |
| Current ratio | 3.57 | 4.20 | 3.20 | 2.44 | 2.04 | 2.21 | 2.44 | 2.37 | 2.46 | 2.06 |
Computed from company filings · US · as of 2026-03-31. Facts plus Stocktoria's own computed scores — not investment advice.